WTIM
CELG

Wilmington Trust Investment Management’s Celgene Corp CELG Stock Holding History

Wilmington Trust Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$1.68M Sell
19,600
-800
-4% -$60.8K 0.34% 47
2014
Q1 		$1.42M Buy
20,400
+5,800
+40% +$459K 0.29% 64
2013
Q4 		$1.23M Sell
14,600
-800
-5% -$63.3K 0.24% 69
2013
Q3 		$1.19M Sell
15,400
-800
-5% -$56.1K 0.25% 71
2013
Q2 		$948K Buy
+16,200
New +$975K 0.2% 82

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wilmington Trust Investment Management's CELG Position: Q2 2014 in Review

Wilmington Trust Investment Management reduced its Celgene Corp (CELG) stake by 3.9% in Q2 2014, selling an estimated $60.8K and leaving 19,600 shares worth $1.68M. The position accounts for 0.34% of the portfolio, ranked #47.

Wilmington Trust Investment Management first reported a position in CELG in Q2 2013 and has held it in 5 quarters since. 995 funds tracked by Wall St. Rank hold CELG as of Q2 2014.

  • Wilmington Trust Investment Management held 19,600 shares of Celgene Corp worth $1.68M as of Q2 2014.
  • Wilmington Trust Investment Management sold 800 Celgene Corp shares in Q2 2014, an estimated $60.8K.
  • Celgene Corp made up 0.34% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #47 holding.
  • Wilmington Trust Investment Management first reported a position in Celgene Corp in Q2 2013 and has held it in 5 quarters since.
  • 995 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.